Clinical Characteristics of Herpes Zoster Developing During Hospitalization Across Underlying Disease Groups: A Single-Center Retrospective Cohort Study
- 1Department of Dermatology, Peking Union Medical College Hospital, Chinese Academy of Medical Sciences and Peking Union Medical College, Beijing, People’s Republic of China
Abstract
Background: Immunocompromised patients have a higher risk of developing herpes zoster. Evidence regarding the clinical characteristics and outcomes of herpes zoster developing during hospitalization, particularly across patients with malignancies and autoimmune diseases, remains limited.
Methods: We conducted a single-center retrospective cohort study between 2015 to 2024. After screening medical records of inpatient cases in departments except dermatology, patients who developed herpes zoster during hospitalization were included. Based on the underlying diseases, patients were divided into immunocompromised groups of malignant solid tumor, hematologic malignancy, or autoimmune disease. We describe the clinical features of new-onset herpes zoster during hospitalization, and analyzed the differences among immunocompromised patients with different underlying diseases and immunocompetent patients. We also explored the factors associated with postherpetic neuralgia.
Results: This study included 401 patients. After screening of immunocompromised status, 309 patients were included in four-group analysis. Patients with hematologic malignancies and autoimmune diseases were younger than immunocompetent patients. Multi-dermatomal or disseminated herpes zoster accounted for 19.4% cases in malignant solid tumor, 30.0% in hematologic malignancy, 24.6% in autoimmune disease, and 20.3% in immunocompetent groups, but the differences were not statistically significant. Immunocompromised groups tended to reported lower pain NRS scores. Crude prevalence of postherpetic neuralgia differed overall (P=0.014), while hematologic malignancy and immunocompetent groups did not differ in the adjusted pairwise comparison (29.8% vs 26.2%; adjusted P=0.649). In the complete-case multivariable model (n=320, 64 events of postherpetic neuralgia), higher pain NRS score (aOR=1.327 per point, 95% CI: 1.166–1.511) and hematologic malignancy (aOR=3.000, 95% CI: 1.346–6.687) were associated with postherpetic neuralgia.
Conclusion: Multi-dermatomal or disseminated herpes zoster accounted for about one-fourth cases in our immunocompromised patients. Hematologic malignancy and greater pain severity were associated with postherpetic neuralgia in adjusted multivariate analyses. Our findings are exploratory and require external validation.
Related
- How age and underlying conditions affect incidence of hospitalization and death after documented COVID-19 diagnosis among individuals aged >=20 years, a retrospective cohort study using PCORnet, April 2022 to March 2025
- Clinical Characteristics Associated with Mortality between Surviving and Non-surviving Adult Patients with Severe Influenza Requiring Hospitalization: An Internet-based, Prospective, Multicenter, Cohort Study in Japan
- Clozapine Augmentation Strategies and Clinical Predictors of Prolonged Tertiary Hospitalization in Clozapine-Resistant Schizophrenia: a Retrospective Cohort Study.
- Clinical burden and predictors of hospitalization in extremity gunshot wounds: A single-center retrospective study.
- Indications for hospitalization, clinical course, and mortality analysis among patients with HIV/AIDS in a tertiary care hospital: a 5-year retrospective study (2021–2025)
BibTeX
@article{xu2026clinical,
title = {{Clinical Characteristics of Herpes Zoster Developing During Hospitalization Across Underlying Disease Groups: A Single-Center Retrospective Cohort Study}},
author = {Jia-Ming Xu and Han-Lin Zhang and Yu-Xuan Li and Hong-Zhong Jin},
journal = {Infection and Drug Resistance},
year = {2026},
month = nov,
doi = {10.2147/idr.s631961},
url = {https://doi.org/10.2147/idr.s631961},
note = {CC BY-NC 4.0},
}
RIS
TY - JOUR
TI - Clinical Characteristics of Herpes Zoster Developing During Hospitalization Across Underlying Disease Groups: A Single-Center Retrospective Cohort Study
AU - Jia-Ming Xu
AU - Han-Lin Zhang
AU - Yu-Xuan Li
AU - Hong-Zhong Jin
PY - 2026
DA - 2026/11/01
JO - Infection and Drug Resistance
DO - 10.2147/idr.s631961
UR - https://doi.org/10.2147/idr.s631961
AB - Background: Immunocompromised patients have a higher risk of developing herpes zoster. Evidence regarding the clinical characteristics and outcomes of herpes zoster developing during hospitalization, particularly across patients with malignancies and autoimmune diseases, remains limited. Methods: We conducted a single-center retrospective cohort study between 2015 to 2024. After screening medical records of inpatient cases in departments except dermatology, patients who developed herpes zoster during hospitalization were included. Based on the underlying diseases, patients were divided into immunocompromised groups of malignant solid tumor, hematologic malignancy, or autoimmune disease. We describe the clinical features of new-onset herpes zoster during hospitalization, and analyzed the differences among immunocompromised patients with different underlying diseases and immunocompetent patients. We also explored the factors associated with postherpetic neuralgia. Results: This study included 401 patients. After screening of immunocompromised status, 309 patients were included in four-group analysis. Patients with hematologic malignancies and autoimmune diseases were younger than immunocompetent patients. Multi-dermatomal or disseminated herpes zoster accounted for 19.4% cases in malignant solid tumor, 30.0% in hematologic malignancy, 24.6% in autoimmune disease, and 20.3% in immunocompetent groups, but the differences were not statistically significant. Immunocompromised groups tended to reported lower pain NRS scores. Crude prevalence of postherpetic neuralgia differed overall (P=0.014), while hematologic malignancy and immunocompetent groups did not differ in the adjusted pairwise comparison (29.8% vs 26.2%; adjusted P=0.649). In the complete-case multivariable model (n=320, 64 events of postherpetic neuralgia), higher pain NRS score (aOR=1.327 per point, 95% CI: 1.166–1.511) and hematologic malignancy (aOR=3.000, 95% CI: 1.346–6.687) were associated with postherpetic neuralgia. Conclusion: Multi-dermatomal or disseminated herpes zoster accounted for about one-fourth cases in our immunocompromised patients. Hematologic malignancy and greater pain severity were associated with postherpetic neuralgia in adjusted multivariate analyses. Our findings are exploratory and require external validation.
SN - 1178-6973
ER -